Mele, Silvia

Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance

Orgaz, J. L., Crosas-Molist, E., Sadok, A., Perdrix-Rosell, A., Maiques, O., Rodriguez-Hernandez, I., Monger, J., Mele, S., Georgouli, M., Bridgeman, V., et al. (2020) · Cancer Cell

Melanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers

Cited by 151

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states

Pellizzari, G., Hoskin, C., Crescioli, S., Mele, S., Gotovina, J., Chiaruttini, G., Bianchini, R., Ilieva, K., Bax, H. J., Papa, S., et al. (2019) · EBioMedicine

Immune cells in cancerMonoclonal and Polyclonal Antibodies Research

Cited by 77